This activity is intended for internal CCAD Physicians

Activity Description:

This activity follows a standardized multidisciplinary team (MDT) approach to the management of neuro-oncology patients. By bringing together specialists from neurology, oncology, neurosurgery, radiology, and pathology, this activity ensures comprehensive case discussions, evidence-based decision-making, and coordinated patient care. Through collaborative expertise, the tumor board aims to optimize treatment strategies, improve clinical outcomes, and uphold best practices in neuro-oncology management.

Target Audience: 

Neurosurgery, Oncology, Radiation oncology, pathology, Radiology.

Learning Objectives:

• Discuss the multiple and the latest up to date modalities/approaches in the treatment of neuro-oncology patients.

Faculty Disclosure:

In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), Cleveland Clinic Abu Dhabi for Continuing Education mitigates all faculty conflicts of interest to ensure CME activities are free of commercial bias.

Activity Director(s): Mohamed ElHammady, MD

The planning committee, faculty, and others in control of content (either individually or as a group) have NO relevant financial relationship(s) to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Accreditation Statement:

Cleveland Clinic Abu Dhabi is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education.

Credit Designation:

This CME Activity is accredited with 1.00 AMA PRA Category 1 Credits™ Participants should claim only the credit commensurate with the extent of their participation in the activity.